Cargando…
COVID-19 patients may become predisposed to pulmonary arterial hypertension
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the current pandemic of coronavirus disease 2019 (COVID-19) that have killed over one million people worldwide so far. To date, over forty million people have officially been identified to be infected with this virus with less t...
Autores principales: | Suzuki, Yuichiro J., Nikolaienko, Sofia I., Shults, Nataliia V., Gychka, Sergiy G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787059/ https://www.ncbi.nlm.nih.gov/pubmed/33444904 http://dx.doi.org/10.1016/j.mehy.2021.110483 |
Ejemplares similares
-
Vasa Vasorum Lumen Narrowing in Brain Vascular Hyalinosis in Systemic Hypertension Patients Who Died of Ischemic Stroke
por: Gychka, Sergiy G., et al.
Publicado: (2020) -
SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells
por: Suzuki, Yuichiro J., et al.
Publicado: (2021) -
Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer’s Disease
por: Ding, Qiyue, et al.
Publicado: (2021) -
Apoptosis-based therapy to treat pulmonary arterial hypertension
por: Suzuki, Yuichiro J., et al.
Publicado: (2016) -
Transmission Electron Microscopy Study of Mitochondria in Aging Brain Synapses
por: Rybka, Vladyslava, et al.
Publicado: (2019)